- Home
- PRQR vs DOUG Comparison
PRQR vs DOUG Comparison
Compare PRQR & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | DOUG |
|---|---|---|
| Founded | 2012 | 1911 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.7M | 219.1M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRQR | DOUG |
|---|---|---|
| Price | $2.10 | $2.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $8.14 | N/A |
| AVG Volume (30 Days) | ★ 566.5K | 394.8K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $18,859,556.00 | ★ $1,030,928,000.00 |
| Revenue This Year | N/A | $17.61 |
| Revenue Next Year | $19.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.67 |
| 52 Week Low | $1.07 | $1.48 |
| 52 Week High | $3.10 | $3.20 |
Technical Indicators
Market Signals| Indicator | PRQR | DOUG |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 48.51 |
| Support Level | $1.92 | $2.23 |
| Resistance Level | $2.28 | $2.43 |
| Average True Range (ATR) | 0.15 | 0.10 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 45.03 | 67.19 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.